Gsa Capital Partners LLP Ani Pharmaceuticals Inc Transaction History

Gsa Capital Partners LLP

$1.32 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 15, 2024	BUY	$58.53 - $68.82 $690,771 - $812,213	11,802 New	11,802 $752,000
Q4 2023 Feb 16, 2024	BUY	$48.72 - $65.43 $455,775 - $612,097	9,355 New	9,355 $515,000
Q2 2022 Aug 09, 2022	SELL	$23.09 - $33.46 $205,962 - $298,463	-8,920 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$26.91 - $47.15 $240,037 - $420,578	8,920 New	8,920 $251,000
Q4 2021 Feb 14, 2022	SELL	$32.97 - $56.85 $868,594 - $1.5 Million	-26,345 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$26.48 - $35.99 $180,302 - $245,055	6,809 Added 34.85%	26,345 $865,000
Q2 2021 Aug 05, 2021	BUY	$31.86 - $38.6 $622,416 - $754,089	19,536 New	19,536 $685,000
Q3 2020 Nov 06, 2020	SELL	$26.38 - $33.1 $214,073 - $268,606	-8,115 Closed	0 $0
Q2 2020 Aug 11, 2020	BUY	$29.93 - $50.1 $74,376 - $124,498	2,485 Added 44.14%	8,115 $262,000
Q1 2020 May 12, 2020	SELL	$30.35 - $67.14 $2,822 - $6,244	-93 Reduced 1.63%	5,630 $229,000
Q4 2019 Feb 12, 2020	SELL	$55.65 - $79.83 $199,004 - $285,472	-3,576 Reduced 38.46%	5,723 $353,000
Q3 2019 Nov 12, 2019	SELL	$64.7 - $85.39 $1.03 Million - $1.35 Million	-15,849 Reduced 63.02%	9,299 $678,000
Q2 2019 Aug 06, 2019	BUY	$67.77 - $82.2 $91,692 - $111,216	1,353 Added 5.69%	25,148 $2.07 Million
Q1 2019 May 15, 2019	SELL	$45.83 - $70.54 $266,043 - $409,484	-5,805 Reduced 19.61%	23,795 $1.68 Million
Q4 2018 Feb 12, 2019	BUY	$41.17 - $56.44 $168,797 - $231,404	4,100 Added 16.08%	29,600 $1.33 Million
Q3 2018 Nov 13, 2018	SELL	$52.95 - $71.34 $5,295 - $7,134	-100 Reduced 0.39%	25,500 $1.44 Million
Q2 2018 Aug 09, 2018	BUY	$56.38 - $68.08 $1.04 Million - $1.26 Million	18,500 Added 260.56%	25,600 $1.71 Million
Q1 2018 May 11, 2018	SELL	$56.98 - $72.41 $45,584 - $57,928	-800 Reduced 10.13%	7,100 $413,000
Q4 2017 Feb 14, 2018	SELL	$53.3 - $74.56 $117,260 - $164,032	-2,200 Reduced 21.78%	7,900 $509,000
Q3 2017 Nov 20, 2017	BUY	$43.46 - $52.49 $438,946 - $530,149	10,100	10,100 $530,000

Others Institutions Holding ANIP

# of Institutions

211

Shares Held

18.8M

Call Options Held

11.7K

Put Options Held

10.5K

View Full List

About ANI PHARMACEUTICALS INC

Ticker ANIP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 17,426,000
Market Cap $986M
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...

More about ANIP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.

Account